воскресенье, 10 апреля 2016 г.

HSBC Reaffirms "Hold" Rating for AstraZeneca plc

HSBC Reaffirms "Hold" Rating for AstraZeneca plc


's stock had its "hold" rating reissued by equities research analysts at HSBC in a research report issued to clients and investors on Thursday, Analyst Ratings.Net reports. They presently have a GBX 4,350 price target on the biopharmaceutical company's stock.



from Biotech News